GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conmed Corp (FRA:EC8) » Definitions » Cyclically Adjusted FCF per Share

Conmed (FRA:EC8) Cyclically Adjusted FCF per Share : €2.10 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Conmed Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Conmed's adjusted free cash flow per share for the three months ended in Mar. 2024 was €0.797. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €2.10 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Conmed's average Cyclically Adjusted FCF Growth Rate was 8.10% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 0.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 3.40% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Conmed was 9.40% per year. The lowest was -1.80% per year. And the median was 5.70% per year.

As of today (2024-06-18), Conmed's current stock price is €66.00. Conmed's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €2.10. Conmed's Cyclically Adjusted Price-to-FCF of today is 31.43.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Conmed was 70.84. The lowest was 18.60. And the median was 36.63.


Conmed Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Conmed's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conmed Cyclically Adjusted FCF per Share Chart

Conmed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.81 1.75 1.99 1.95 2.04

Conmed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.90 1.96 2.05 2.04 2.10

Competitive Comparison of Conmed's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Conmed's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conmed's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conmed's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Conmed's Cyclically Adjusted Price-to-FCF falls into.



Conmed Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Conmed's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.797/131.7762*131.7762
=0.797

Current CPI (Mar. 2024) = 131.7762.

Conmed Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.088 100.560 0.115
201409 0.308 100.428 0.404
201412 0.657 99.070 0.874
201503 0.357 99.621 0.472
201506 0.209 100.684 0.274
201509 0.318 100.392 0.417
201512 0.285 99.792 0.376
201603 -0.627 100.470 -0.822
201606 0.417 101.688 0.540
201609 0.701 101.861 0.907
201612 0.317 101.863 0.410
201703 0.427 102.862 0.547
201706 0.414 103.349 0.528
201709 0.289 104.136 0.366
201712 0.513 104.011 0.650
201803 0.603 105.290 0.755
201806 0.508 106.317 0.630
201809 -0.003 106.507 -0.004
201812 0.606 105.998 0.753
201903 -0.242 107.251 -0.297
201906 0.501 108.070 0.611
201909 0.967 108.329 1.176
201912 1.043 108.420 1.268
202003 0.027 108.902 0.033
202006 0.056 108.767 0.068
202009 0.919 109.815 1.103
202012 0.433 109.897 0.519
202103 0.515 111.754 0.607
202106 0.800 114.631 0.920
202109 0.417 115.734 0.475
202112 0.825 117.630 0.924
202203 -0.087 121.301 -0.095
202206 0.414 125.017 0.436
202209 0.623 125.227 0.656
202212 -0.535 125.222 -0.563
202303 -0.242 127.348 -0.250
202306 0.643 128.729 0.658
202309 1.204 129.860 1.222
202312 1.500 129.419 1.527
202403 0.797 131.776 0.797

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Conmed  (FRA:EC8) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Conmed's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=66.00/2.1
=31.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Conmed was 70.84. The lowest was 18.60. And the median was 36.63.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Conmed Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Conmed's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Conmed (FRA:EC8) Business Description

Traded in Other Exchanges
Address
11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Conmed (FRA:EC8) Headlines

No Headlines